CEO & Founder | WearTech Therapeutics
Jim has over 30 years experience and success in medical device business in the US, Asia and European Markets. He has been involved 6 startup companies with over 30 new medical device launches from St. Jude Heart valves to the first insulin pump. He has held sales management responsibilities with 3M, J&J, Auto-Syringe, Beech Medical, and Medex. Having a strong a strong skill set in understanding product and marketing development with a clear understanding on developing research projects, he has lead numerous successful product launches. He has been involved in the first insulin pumps studies; St. Jude heart valve IRB studies; first PCA infusion pump published study; a NIH Grant on accurate drug delivery study for pediatric patients; chemotherapy research at M.D. Anderson; and 20 published research studies at Prizm Medical.
Prior to forming Prizm Medical, Inc., Mr. Johnson was co-founder and Vice President of Sales and Marketing for Medfusion, Inc, a medical products company specializing in the development drug delivery devices for ambulatory infusion market and syringe infusion pump technology for anesthesia and pediatrics. Mr. Johnson managed product development to Sales and Marketing at Medfusion for seven years through start-up, growth, and subsequent exit sale to Medex. During this period, Medfusion grew from 3 employees to 280 creating $25 million in syringe pump sales and $6 million in ambulatory pumps. He remained at Medex during a three year buyout with management responsibility where he was involve in merger of $18 million infusion pump company leading to the management of a $48 million Infusion Systems Division with 108 sales and marketing people.
He founded Prizm Medical, Inc. in which the company developed the World’s first garment electrodes, “Intelligent Textiles for Medicine®”, in the form of gloves, stockings, and sleeves as well as integrating this technology into orthopedic soft bracing. The “Intelligent Textiles®” are powered by the world smallest HVPG stimulators the Micro-Z ™and Micro-z Mini™ that offer a unique copyrighted nocturnal therapy while sleeping. The major market targets are pain relief, Diabetic Foot Disease, sport medicine, stroke rehab and wound healing. In the past 16 years the company has treated greater than 250,000 patients with 20 published clinical research studies and with several studies in process. Prizm products are FDA (nine 510ks), European MDD and Medicare approved devices with coding for reimbursement. Prizm’s devices are also approved in Japan, Europe, Canada, Hong Kong and Taiwan.
Prizm won a successful three years battle with the FDA in getting all Prizm products over-the-counter/retail, thus breaking a 35 year prescription only regulatory glass ceiling. Prizm has launched a new stand alone OTC medical device company, WearTech Therapeutics.
He received a BA in Business Administration from Catawba College. In addition, he has post-graduate work at University of Dayton and Georgia Tech. In 1978 he participated in a Johnson/Johnson sponsored management assessment center at Penn State, which lead to a Johnson/Johnson scholarship to Wharton Business School, but he declined and accepted a national sales management position.
Personal activities include: Golf, Scuba Diving, Snow Skiing, and Bible Studies